220 related articles for article (PubMed ID: 29183921)
1. Diagnostic immunohistochemistry in gynaecological neoplasia: a brief survey of the most common scenarios.
Kuhn E; Ayhan A
J Clin Pathol; 2018 Feb; 71(2):98-109. PubMed ID: 29183921
[TBL] [Abstract][Full Text] [Related]
2. Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.
Kang EY; Tessier-Cloutier B; Duggan MA; Stewart CJR; Lee CH; Köbel M
Histopathology; 2021 Aug; 79(2):160-167. PubMed ID: 33432679
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry in gynaecological pathology: a review.
Marjoniemi VM
Pathology; 2004 Apr; 36(2):109-19. PubMed ID: 15203746
[TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach.
Armes JE; Bowlay G; Lourie R; Venter DJ; Price G
Pathology; 2010; 42(6):534-9. PubMed ID: 20854071
[TBL] [Abstract][Full Text] [Related]
5. Application of immunohistochemistry in breast pathology: a review and update.
Liu H
Arch Pathol Lab Med; 2014 Dec; 138(12):1629-42. PubMed ID: 25427042
[TBL] [Abstract][Full Text] [Related]
6. Ten problematical issues identified by pathology review for multidisciplinary gynaecological oncology meetings.
McCluggage WG
J Clin Pathol; 2012 Apr; 65(4):293-301. PubMed ID: 22011450
[TBL] [Abstract][Full Text] [Related]
7. Perivascular epithelioid tumours (PEComas) of the gynaecological tract.
Conlon N; Soslow RA; Murali R
J Clin Pathol; 2015 Jun; 68(6):418-26. PubMed ID: 25750268
[TBL] [Abstract][Full Text] [Related]
8. The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.
Singh N; Gilks CB
Histopathology; 2017 Jan; 70(1):56-69. PubMed ID: 27960241
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in immunohistochemistry in gynaecological pathology.
McCluggage WG
Histopathology; 2002 Apr; 40(4):309-26. PubMed ID: 11943015
[TBL] [Abstract][Full Text] [Related]
10. An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology.
Kalampokas E; Payne F; Nomikos A; Gurumurthy M
Gynecol Oncol; 2018 Aug; 150(2):378-386. PubMed ID: 29792263
[TBL] [Abstract][Full Text] [Related]
11. Gynecological Sarcomas: Molecular Characteristics, Behavior, and Histology-Driven Therapy.
Libertini M; Hallin M; Thway K; Noujaim J; Benson C; van der Graaf W; Jones RL
Int J Surg Pathol; 2021 Feb; 29(1):4-20. PubMed ID: 32909482
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast-rich, proximal-type epithelioid sarcoma: clinicopathologic features of 3 unusual cases expanding the histomorphological spectrum.
Rekhi B; Verma A; Jambhekar NA; Menon S; Laskar S; Merchant N; Mittal N; Puri A
Ann Diagn Pathol; 2016 Apr; 21():39-43. PubMed ID: 27040929
[TBL] [Abstract][Full Text] [Related]
13. [Current classification of malignant tumours in gynecological oncology--part I].
Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
Ceska Gynekol; 2011 Sep; 76(4):279-84. PubMed ID: 22026069
[TBL] [Abstract][Full Text] [Related]
14. Extravascular migratory metastasis in gynaecological carcinosarcoma.
Dyke JM; Crook ML; Platten M; Stewart CJ
Histopathology; 2014 Sep; 65(3):363-70. PubMed ID: 24734932
[TBL] [Abstract][Full Text] [Related]
15. [Current classification of malignant tumours in gynecological oncology--part II].
Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
Ceska Gynekol; 2011 Oct; 76(5):360-6. PubMed ID: 22132636
[TBL] [Abstract][Full Text] [Related]
16. A preliminary study of the immunohistochemical detection of a novel tumour marker, 22-1-1 antigen, in gynaecological cancer specimens.
Razvi K; Sonoda K; Lee YS; Tham KF; Lim FK; Yong EL
Ann Acad Med Singap; 1999 May; 28(3):392-4. PubMed ID: 10575525
[TBL] [Abstract][Full Text] [Related]
17. Pax8: a marker for carcinoma of Müllerian origin in serous effusions.
Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E
Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry in Gynecologic Pathology: An Example-Based Practical Update.
Buza N; Hui P
Arch Pathol Lab Med; 2017 Aug; 141(8):1052-1071. PubMed ID: 28745567
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition in carcinomas of the female genital tract.
Stewart CJ; McCluggage WG
Histopathology; 2013 Jan; 62(1):31-43. PubMed ID: 23240668
[TBL] [Abstract][Full Text] [Related]
20. [Histopathological diagnostic concordance in bone and soft tissue sarcomas between two comprehensive cancer centers from eastern and western Europe: a collaborative experience].
Somcutian O; Buiga R; Galatir M; Tudor Eniu D; Rachieru C; Coza D; Terrier P
Ann Pathol; 2015 Jan; 35(1):32-40. PubMed ID: 25541117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
